Best practices in mental health最新文献_第4页

ASHP Guidelines on Medication Cost Management Strategies for Hospitals and Health Systems 医院和卫生系统药物成本管理策略的ASHP指南

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.319

{"title":"ASHP Guidelines on Medication Cost Management Strategies for Hospitals and Health Systems","authors":"","doi":"10.37573/9781585286560.319","DOIUrl":"https://doi.org/10.37573/9781585286560.319","url":null,"abstract":"Because medication costs comprise the majority of healthsystem pharmacy budgets and continue to increase faster than other health care expenditures, drug costs are a constant target for cost containment initiatives. The purpose of these guidelines is to provide guidance on medication-costmanagement strategies. These guidelines recommend techniques to manage drug costs in hospitals and health systems. The guidelines focus on drug use in inpatient settings and hospital clinics, where health-system pharmacies typically have responsibility for purchasing and distributing drugs. Strategies for other settings, such as managed care and ambulatory care settings, and strategies for revenue optimization are beyond the scope of this document. Although revenue optimization and medication cost management are complementary approaches to improving the financial performance of pharmacy departments, revenue optimization is best addressed through literature specific to that topic2,3 and is not extensively reviewed in this document. These guidelines examine methods for nonlabor pharmaceutical cost containment, focusing primarily on variable costs (costs dependent on patient volume) and direct drug costs. Fixed and indirect costs, such as labor to prepare or administer medication, nonpharmaceutical materials, and overhead, are also beyond the scope of these guidelines. There is also not an attempt to consider the impact of drug costs and drug-cost-management strategies on other hospital departments (e.g., laboratory, respiratory care) or on the total health care costs once the patient leaves the acute care setting. Although not discussed here, these shifts in drug costs are important to consider as drug therapies influence other health care costs, and pharmacists should lead efforts to promote the value medications provide across the hospital and health care system. A broad range of drug-cost-management strategies exist throughout hospitals and health systems. Some approaches are relatively straightforward and can be implemented within the pharmacy. Other approaches are more complex and require high-level strategic planning and extensive collaboration throughout the hospital. Successful drug cost management requires systematic attention to and integration of both approaches. Because of the different nature of various drug-costmanagement activities, these guidelines present information at different levels of complexity appropriate to the approach being described. When selecting and implementing drug-cost-management strategies, it is essential that pharmacists remain mindful of patient safety and the quality of patient care. Drug-cost-containment initiatives must never compromise the department’s ability to provide the best possible care to patients. In many cases, it is prudent and necessary to monitor and evaluate the safety and outcomes of drug-costmanagement projects. Fortunately, many drug-cost-containment strategies have little or no potential for detrimental ef","PeriodicalId":89328,"journal":{"name":"Best practices in mental health","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89187131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 27

Expression of Therapeutic Purpose of Prescribing (0305) 处方治疗目的表达(0305)

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.101

引用次数: 0

Appropriate Use of Testosterone (1536) 适当使用睾酮(1536)

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.252

引用次数: 0

ASHP Guidelines on Home Infusion Pharmacy Services ASHP家庭输液药房服务指南

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.350

引用次数: 0

Direct and Indirect Remuneration Fees (1814) 直接及间接酬金费用(1814年)

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.323

引用次数: 0

ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients ASHP治疗立场声明药物治疗在预防住院患者静脉血栓栓塞中的作用

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.364

引用次数: 0

ASHP Technical Assistance Bulletin on Compounding Nonsterile Products in Pharmacies 美国食品卫生标准局关于药房配制非无菌产品的技术援助公报

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.044

引用次数: 7

Clinical Investigations of Drugs Used in Elderly and Pediatric Patients (1723) 老年儿童用药情况调查(1723年)

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.355

引用次数: 0

Controlled Substance Diversion Prevention (1709) 防止管制物质转移(1709)

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.028

引用次数: 0

FDA Oversight of Laboratory-Developed Tests (1412) FDA对实验室开发测试的监督(1412)

Best practices in mental health Pub Date : 2019-12-01 DOI: 10.37573/9781585286560.137

引用次数: 1